Pharmaceutical Executive November 28, 2023
Nicholas Saraceno

Researchers highlight steps to be taken in the European Union to manage the challenge of ongoing drug shortages.

When it comes to mitigation and prevention of drug shortages, notifying the affected parties regarding potential threats is crucial. The need for proactive action has been amplified in light of ongoing drug shortages that continue to impact many regions beyond the United States.

In Europe, there have been requirements in place since 2019 requiring pharmaceutical companies in both in the European Union (EU) and European Economic Area (EEA) to notify authorities of drug shortages a minimum of two months in advance. A study published by the Journal of Pharmaceutical Policy and Practice1explores how the notification process in the region works, while diving...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech, Supply Chain, Survey / Study, Technology, Trends
Mark Cuban: A Master Disrupter for American Healthcare
Despite Trump’s Tough Talk On PBMs, GOP House Lets Them Off The Hook
What's next for Amazon in healthcare?
How has U.S. Spending on Health Care Changed Over Time?
Bringing genomics closer to patients: 3 takeaways from Henry Ford Health

Share This Article